AIM ImmunoTech Inc. Share Price AIM

$0.3

▲

0.02

(7.14%)

Last updated on July 7, 2026 at 5:30 am IST

$₹

Check the interactive AIM ImmunoTech Inc. Stock chart to analyse performance

AIM ImmunoTech Inc. stock performance

as on July 7, 2026 at 5:30 am IST

Today's Low:$0.29
Today's High:$0.30
$0.30
4.57%
Downside
Day's Volatility :4.57%
Upside
0.0%
52 Weeks Low:$0.21
52 Weeks High:$20.33
$0.30
30.0%
Downside
52 Weeks Volatility :98.97%
Upside
98.52%

AIM ImmunoTech Inc. Stock Returns

Period	AIM ImmunoTech Inc.	Index (Russel 2000)
3 Months	-45.66%	0.0%
6 Months	-78.44%	0.0%
1 Year	-96.64%	0.0%
3 Years	-57.54%	0.0%

AIM ImmunoTech Inc. Key Stats

Check AIM ImmunoTech Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.28
Open	$0.2892
Today's High	$0.3
Today's Low	$0.2863
Market Capitalization	$7.8M
Today's Volume	$632.5K
52 Week High	$20.3297
52 Week Low	$0.21
Revenue TTM	$94.0K
EBITDA	$-10.1M
Earnings Per Share (EPS)	$-4.31
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-3138.91%

Stock Returns calculator for AIM ImmunoTech Inc. Stock including INR - Dollar returns

The AIM ImmunoTech Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

AIM ImmunoTech Inc. investment value today

Current value as on today

Returns

(0%)

Returns from AIM ImmunoTech Inc. Stock

(0%)

Dollar Impact

(0%)

Indian investors sentiment towards AIM ImmunoTech Inc. Stock

-57%

Period: Jun 6, 2026 to Jul 6, 2026. Change in 30 Days versus previous period

Search interest for AIM ImmunoTech Inc. Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on AIM ImmunoTech Inc. Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for AIM ImmunoTech Inc.(by analysts ranked 0 to 5 stars)

AIM ImmunoTech Inc. Share Price Target

What analysts predicted

Upside of 1650.0%

Target:

$5.25

Current:

$0.30

AIM ImmunoTech Inc. share price target is $5.25, a slight Upside of 1650.0% compared to current price of $0.30 as per analysts' prediction.

AIM ImmunoTech Inc. Stock Insights

Price Movement
In the last 1 month, AIM stock has moved down by -42.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 21.0K → 22.0K (in $), with an average increase of 4.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.17M → -3.02M (in $), with an average increase of 38.1% per quarter
AIM vs RVMD (1 yr)
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 418.1% return, outperforming this stock by 514.7%
AIM vs RVMD (3 yr)
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 619.9% return, outperforming this stock by 674.6%
Price to Sales
ForAIM every $1 of sales, investors are willing to pay $8.0, whereas for Revolution Medicines, Inc. Common Stock, the investors are paying $37998.0 for every $1 of sales.

AIM ImmunoTech Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$163.0K	-
Net Income	$-14.4M	-
Net Profit Margin	-8.8K%	-

	FY21	Y/Y Change
Revenue	$135.0K	↓ 17.18%
Net Income	$-19.1M	↑ 17.65%
Net Profit Margin	-14.2K%	↓ 4193.92%

	FY21	Y/Y Change
Revenue	$135.0K	↓ 17.18%
Net Income	$-19.1M	↑ 17.65%
Net Profit Margin	-14.2K%	↓ 4193.92%

	FY22	Y/Y Change
Revenue	$141.0K	↑ 4.44%
Net Income	$-19.4M	↓ 9.61%
Net Profit Margin	-13.8K%	↑ 2144.78%

	FY22	Y/Y Change
Revenue	$141.0K	↑ 4.44%
Net Income	$-19.4M	↓ 9.61%
Net Profit Margin	-13.8K%	↑ 2144.78%

	FY23	Y/Y Change
Revenue	$202.0K	↑ 43.26%
Net Income	$-29.0M	↑ 37.35%
Net Profit Margin	-14.3K%	↑ 616.99%

	FY23	Y/Y Change
Revenue	$202.0K	↑ 43.26%
Net Income	$-29.0M	↑ 37.35%
Net Profit Margin	-14.3K%	↑ 616.99%

	FY24	Y/Y Change
Revenue	$170.0K	↓ 15.84%
Net Income	$-17.3M	↓ 40.2%
Net Profit Margin	-10.2K%	↑ 4149.38%

	FY24	Y/Y Change
Revenue	$170.0K	↓ 15.84%
Net Income	$-17.3M	↓ 40.2%
Net Profit Margin	-10.2K%	↑ 4149.38%

	FY25	Y/Y Change
Revenue	$88.0K	↓ 48.24%
Net Income	$-14.0M	↓ 19.41%
Net Profit Margin	-15.9K%	↓ 5673.12%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q1 FY24	Q/Q Change
Revenue	$40.0K	-
Net Income	$-5.8M	-
Net Profit Margin	-14.5K%	-

	Q2 FY24	Q/Q Change
Revenue	$50.0K	↑ 25.0%
Net Income	$-1.8M	↓ 68.44%
Net Profit Margin	-3.7K%	↑ 10870.5%

	Q2 FY24	Q/Q Change
Revenue	$50.0K	↑ 25.0%
Net Income	$-1.8M	↓ 68.44%
Net Profit Margin	-3.7K%	↑ 10870.5%

	Q3 FY24	Q/Q Change
Revenue	$35.0K	↓ 30.0%
Net Income	$-3.7M	↑ 101.53%
Net Profit Margin	-10.6K%	↓ 6899.43%

	Q4 FY24	Q/Q Change
Revenue	$45.0K	↑ 28.57%
Net Income	$-6.0M	↑ 61.27%
Net Profit Margin	-13.3K%	↓ 2688.57%

	Q1 FY25	Q/Q Change
Revenue	$16.0K	↓ 64.44%
Net Income	$-3.7M	↓ 37.91%
Net Profit Margin	-23.2K%	↓ 9896.25%

	Q2 FY25	Q/Q Change
Revenue	$25.0K	↑ 56.25%
Net Income	$-2.8M	↓ 24.59%
Net Profit Margin	-11.2K%	↑ 11980.25%

	Q3 FY25	Q/Q Change
Revenue	$26.0K	↑ 4.0%
Net Income	$-3.3M	↑ 17.54%
Net Profit Margin	-12.6K%	↓ 1454.77%

	Q4 FY25	Q/Q Change
Revenue	$21.0K	↓ 19.23%
Net Income	$-4.2M	↑ 27.13%
Net Profit Margin	-19.9K%	↓ 7250.18%

	Q1 FY26	Q/Q Change
Revenue	$22.0K	↑ 4.76%
Net Income	$-3.0M	↓ 27.59%
Net Profit Margin	-13.7K%	↑ 6140.04%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$-643.0K	-

	FY21	Y/Y Change
Profit	$-715.0K	-

	FY22	Y/Y Change
Profit	$141.0K	-

	FY23	Y/Y Change
Profit	$160.0K	-

	FY24	Y/Y Change
Profit	$139.0K	-

	FY25	Y/Y Change
Profit	$-250.0K	↓ 279.86%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q1 FY24	Q/Q Change
Profit	$-26.0K	-

	Q2 FY24	Q/Q Change
Profit	$42.0K	↓ 261.54%

	Q2 FY24	Q/Q Change
Profit	$42.0K	↓ 261.54%

	Q3 FY24	Q/Q Change
Profit	$27.0K	↓ 35.71%

	Q4 FY24	Q/Q Change
Profit	$96.0K	↑ 255.56%

	Q1 FY25	Q/Q Change
Profit	$6.0K	↓ 93.75%

	Q2 FY25	Q/Q Change
Profit	$15.0K	↑ 150.0%

	Q3 FY25	Q/Q Change
Profit	$-96.0K	↓ 740.0%

	Q4 FY25	Q/Q Change
Profit	$-19.0K	↓ 80.21%

	Q1 FY26	Q/Q Change
Profit	$-25.0K	↑ 31.58%

FY22

FY23

FY24

FY25

	FY22	Y/Y Change
Operating Cash Flow	$-16.1M	↑ 15.35%
Investing Cash Flow	$11.0M	↓ 1841.36%
Financing Cash Flow	$80.0K	↓ 99.02%

	FY23	Y/Y Change
Operating Cash Flow	$-21.3M	↑ 32.03%
Investing Cash Flow	$-832.0K	↓ 107.57%
Financing Cash Flow	$485.0K	↑ 506.25%

	FY23	Y/Y Change
Operating Cash Flow	$-21.3M	↑ 32.03%
Investing Cash Flow	$-832.0K	↓ 107.57%
Financing Cash Flow	$485.0K	↑ 506.25%

	FY24	Y/Y Change
Operating Cash Flow	$-14.9M	↓ 29.99%
Investing Cash Flow	$4.7M	-
Financing Cash Flow	$6.4M	↑ 1228.66%

	FY25	Y/Y Change
Operating Cash Flow	$-11.0M	↓ 26.4%
Investing Cash Flow	$1.9M	↓ 60.62%
Financing Cash Flow	$10.4M	↑ 61.2%

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.0M	↑ 27.17%
Investing Cash Flow	$3.7M	↑ 1008.98%
Financing Cash Flow	$1.0M	↑ 656.93%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-2.4M	↓ 40.3%
Investing Cash Flow	$898.0K	↓ 75.76%
Financing Cash Flow	$660.0K	↓ 36.35%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.5M	↓ 35.15%
Investing Cash Flow	$754.0K	↓ 16.04%
Financing Cash Flow	$355.0K	↓ 46.21%

	Q3 FY25	Q/Q Change
Operating Cash Flow	$-5.1M	↑ 231.74%
Investing Cash Flow	$296.0K	↓ 60.74%
Financing Cash Flow	$6.7M	↑ 1774.37%

	Q4 FY25	Q/Q Change
Operating Cash Flow	$-2.0M	↓ 60.9%
Investing Cash Flow	$-95.0K	↓ 132.09%
Financing Cash Flow	$2.7M	↓ 59.14%

	Q1 FY26	Q/Q Change
Operating Cash Flow	$-2.7M	↑ 36.91%
Investing Cash Flow	$-37.0K	↓ 61.05%
Financing Cash Flow	$5.6M	↑ 105.48%

AIM ImmunoTech Inc. Technicals Summary

Sell

Neutral

Buy

AIM ImmunoTech Inc. is currently in a neutral trading position according to technical analysis indicators.

AIM ImmunoTech Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
AIM ImmunoTech Inc.	-42.76%	-78.44%	-96.64%	-57.54%	-85.36%
Regeneron Pharmaceuticals, Inc. Common Stock	6.29%	-16.32%	20.76%	-7.61%	13.03%
Revolution Medicines, Inc. Common Stock	27.95%	137.93%	418.11%	598.24%	498.58%
Vertex Pharmaceuticals Incorporated Common Stock	19.56%	13.07%	15.28%	53.74%	167.82%
Alnylam Pharmaceuticals, Inc. Common Stock	7.15%	-22.97%	-3.42%	56.67%	81.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
AIM ImmunoTech Inc.	NA	NA	0.71	-0.63	-31.39	-0.87	NA	0.26
Regeneron Pharmaceuticals, Inc. Common Stock	15.97	15.97	1.13	46.21	0.15	0.06	0.01	308.33
Revolution Medicines, Inc. Common Stock	NA	NA	NA	-8.05	-0.77	-0.38	NA	7.49
Vertex Pharmaceuticals Incorporated Common Stock	31.36	31.36	1.96	19.15	0.24	0.12	NA	76.18
Alnylam Pharmaceuticals, Inc. Common Stock	78.79	78.79	0.54	9.42	0.9	0.1	NA	8.06

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
AIM ImmunoTech Inc.	Buy	$7.8M	-85.36%	NA	0.0%
Regeneron Pharmaceuticals, Inc. Common Stock	Buy	$68.6B	13.03%	15.97	29.65%
Revolution Medicines, Inc. Common Stock	Buy	$40.2B	498.58%	NA	0.0%
Vertex Pharmaceuticals Incorporated Common Stock	Buy	$134.0B	167.82%	31.36	35.51%
Alnylam Pharmaceuticals, Inc. Common Stock	Buy	$41.8B	81.47%	78.79	12.55%

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Organization	AIM ImmunoTech Inc.
Employees	19
CEO	Mr. Thomas K. Equels Esq., J.D., M.S.
Industry	Healthcare

Key Management of AIM ImmunoTech Inc.

Name	Title
Mr. Thomas K. Equels Esq., J.D., M.S.	Executive Vice Chairman, CEO & President
Mr. Robert Dickey IV, B.A., M.B.A.	Chief Financial Officer
Mr. Peter W. Rodino III, Esq., J.D.	COO, Executive Director of Governmental Relations, General Counsel & Secretary
Ann Marie E. Coverly	Director of Administration & Human Resources and Deputy Investor Relations Coordinator
Dr. Christopher Nicodemus FACP, M.D.	Member of Scientific Advisory Board & Consulting Science Officer

Important FAQs about investing in AIM Stock from India :

What is AIM ImmunoTech Inc. share price today?

AIM ImmunoTech Inc. share price today is $0.30 as on July 7, 2026 at 5:30 am IST at the close of the market. AIM ImmunoTech Inc. share today touched a day high of $0.30 and a low of $0.29.

What is the 52 week high and 52 week low for AIM ImmunoTech Inc. share?

AIM ImmunoTech Inc. share touched a 52 week high of $20.33 and a 52 week low of $0.21. AIM ImmunoTech Inc. stock price today i.e. July 7, 2026 at 5:30 am IST is closed at $0.30, lower by 98.52% versus the 52 week high.

How to invest in AIM ImmunoTech Inc. Stock (AIM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AIM ImmunoTech Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AIM ImmunoTech Inc. Shares that will get you 5.0000 shares as per AIM ImmunoTech Inc. share price of $0.30 per share as on July 7, 2026 at 5:30 am IST.

What is the minimum amount required to buy AIM ImmunoTech Inc. Stock (AIM) from India?

Indian investors can start investing in AIM ImmunoTech Inc. (AIM) shares with as little as ₹95.3725 or $1 (as of July 07, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹953.73 in AIM ImmunoTech Inc. stock (as per the Rupee-Dollar exchange rate as on July 07, 2026). Based on AIM ImmunoTech Inc. share’s latest price of $0.30 as on July 7, 2026 at 5:30 am IST, you will get 33.3333 shares of AIM ImmunoTech Inc.. Learn more about fractional shares .

What are the returns that AIM ImmunoTech Inc. has given to Indian investors in the last 5 years?

AIM ImmunoTech Inc. stock has given -85.36% share price returns and 28.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?